Go Pro

iShares U.S. Pharmaceuticals ETF (IHE) News Today

iShares U.S. Pharmaceuticals ETF logo
$105.42 +0.26 (+0.25%)
As of 04:10 PM Eastern

iShares U.S. Pharmaceuticals ETF Latest News

iShares U.S. Pharmaceuticals ETF
IHE: Healthcare Dashboard For May
IHE: U.S. Pharmaceuticals ETF With Excellent GARP Features
iShares Dow Jones US Pharmaceuticals ETF : IHE
IHE: Pharma Powerhouse ETF Despite High Fees And Valuation
IHE: Healthcare Dashboard For June
IHE Contraction Is Not Justified By Fundamental Data
Healthcare ETFs tumble as UnitedHealth stock weighs
Pharmaceutical Stocks - Best Pharmaceutical Stocks to Buy (IHE)
Along with biotechnology and biotech companies, the pharma industry is a major part of the overall healthcare market. Pharmaceutical companies include some of the biggest stock gainers and some of the best growth stocks on the market. The pharmaceutical market has many amazing stocks to watch. The pharma industry may also be a good investment for those looking for dividend stocks since so many of the largest pharmaceutical companies pay a dividend to its shareholders. Though the industry has plenty of potential for growth, investors should also be aware that pharma stocks—especially smaller startups—can be risky. Investors buying pharma stocks should make sure to do their research and only invest in pharma stocks as part of a diversified portfolio.
SEC Approves Spot Ether ETFs
ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat
iShares U.S. Pharmaceuticals ETF (IHE)
EIS: A Strong Recovery Play
IHE iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF Media Mentions By Week

iShares U.S. Pharmaceuticals ETF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IHE
News Sentiment

0.00

0.59

Average

News Sentiment

iShares U.S. Pharmaceuticals ETF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IHE Articles
This Week

0

0

IHE Articles
Average Week

iShares U.S. Pharmaceuticals ETF Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
1
Page Views
867
+43%
Get iShares U.S. Pharmaceuticals ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for IHE and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for iShares U.S. Pharmaceuticals ETF dated 8/21/2026.
From Our Partners